Real Menopause Peptides vs the Peptide Clinic
Two new nonhormonal menopause drugs target the brain circuit behind hot flashes, and they work. The wellness peptides sold for menopause have no such evidence. One of those is not like the other.
Peptides in Women’s Health · Part 5 of 7
Menopause is the clearest split in the series: tested drugs that target the brain circuit behind hot flashes, versus an untested peptide market.
Menopause has its own peptide story, and it splits cleanly in two. On one side, two new nonhormonal drugs that quiet hot flashes by targeting the brain circuit that produces them. On the other, a peptide clinic market selling injections for menopause with almost no evidence behind them. Both use the word peptide. Only one side has trials.
Hot flashes start in the brain. A cluster of neurons that helps run the body’s thermostat uses signals including a peptide called neurokinin B. As estrogen falls in menopause, those neurons fire too easily, and the result is the sudden heat and sweat that millions of women know. The new drugs do not replace a peptide. They block the receptor that the overactive signal lands on. That is pathway pharmacology, and it went through clinical trials.
A woman who cannot or does not want to take estrogen now has real nonhormonal options that work. She also faces a market that will sell her unrelated injections labeled peptide therapy for the same symptoms. The difference between the two is the difference between a tested drug and a hopeful guess, and it is worth real money and real safety.
Paid subscribers continue below.
